Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Transcode Therapeutics Inc (RNAZ)

Transcode Therapeutics Inc (RNAZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Investigational Immunotherapy Treatments Offering Promise in Treating Pancreatic Cancer as Risk Factors Rise FinancialNewsMedia - Tue Sep 26, 2023

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:VACC),(NASDAQ:BPTS),(NASDAQ:RNAZ),(NYSE:BMY) EQNX::TICKER_END

BMY : 40.06 (-0.96%)
ONCY : 1.0100 (+2.02%)
ONC.TO : 1.41 (+2.92%)
VACC : 5.00 (+11.36%)
BPTS : 8.22 (-15.28%)
RNAZ : 0.8681 (-7.65%)
Investigational Immunotherapy Treatments Offering Promise in Treating Pancreatic Cancer as Risk Factors Rise PR Newswire - Tue Sep 26, 2023

/PRNewswire/ -- FinancialNewsMedia.com News Commentary - There has been a rise in the prevalence of cancer in the past several years. Overall, there is a rapid...

ONC.TO : 1.41 (+2.92%)
ONCY : 1.0100 (+2.02%)
VACC : 5.00 (+11.36%)
BPTS : 8.22 (-15.28%)
RNAZ : 0.8681 (-7.65%)
BMY : 40.06 (-0.96%)
Biotechs Race for New Treatments as Breast Cancer Therapeutics Market Could Reach $15 Billion by 2028 FinancialNewsMedia - Thu Dec 8, 2022

EQNX::TICKER_START (NASDAQ:ONCY),(NASDAQ:GILD),(NYSE:BMY),(NASDAQ:RXDS),(NASDAQ:RNAZ) EQNX::TICKER_END

ONCY : 1.0100 (+2.02%)
ONC.TO : 1.41 (+2.92%)
GILD : 66.59 (-2.65%)
RXDX : 199.92 (+0.09%)
RNAZ : 0.8681 (-7.65%)
BMY : 40.06 (-0.96%)
Biotechs Race for New Treatments as Breast Cancer Therapeutics Market Could Reach $15 Billion by 2028 PR Newswire - Thu Dec 8, 2022

/PRNewswire/ -- FinancialNewsMedia.com News Commentary - According to a report from Global Market Insights the Breast Cancer Therapeutics Market size, which...

ONC.TO : 1.41 (+2.92%)
ONCY : 1.0100 (+2.02%)
GILD : 66.59 (-2.65%)
BMY : 40.06 (-0.96%)
RXDX : 199.92 (+0.09%)
RNAZ : 0.8681 (-7.65%)
Biotech Sees Massive Rally On Major Announcement Yolowire - Wed Dec 7, 2022

A Boston-based %Biotech company caught the attention of the trading community on Wednesday after it was announced that the company withdrew the Registration Statement on Form S-1 it filed with the U.S....

RNAZ : 0.8681 (-7.65%)
Biotechs with Evolving Therapies Have Potential to Revolutionize Treatments for Pancreatic Cancer FinancialNewsMedia - Thu Nov 10, 2022

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:MACK),(NASDAQ:NRBO),(NYSE:MRK),(NASDAQ:RNAZ), EQNX::TICKER_END

ONCY : 1.0100 (+2.02%)
ONC.TO : 1.41 (+2.92%)
MACK : 15.13 (unch)
NRBO : 4.47 (-4.48%)
MRK : 125.85 (-1.46%)
RNAZ : 0.8681 (-7.65%)
Biotechs with Evolving Therapies Have Potential to Revolutionize Treatments for Pancreatic Cancer PR Newswire - Thu Nov 10, 2022

/PRNewswire/ -- FinancialNewsMedia.com News Commentary - The pancreatic cancer treatment market is fiercely competitive. To maintain the escalating market...

ONC.TO : 1.41 (+2.92%)
ONCY : 1.0100 (+2.02%)
MACK : 15.13 (unch)
NRBO : 4.47 (-4.48%)
MRK : 125.85 (-1.46%)
RNAZ : 0.8681 (-7.65%)
Positive Results Causes Pop In Biotech Stock Yolowire - Wed Oct 26, 2022

A Boston-based %Biotech company really captured the attention of traders on Wednesday after the it reported Positive Preclinical Results with its Lead Candidate, TTX-MC138, in Pancreatic Adenocarcinoma....

RNAZ : 0.8681 (-7.65%)
TransCode Therapeutics Announces Expansion of Global RNA Oncology Patent Portfolio Globe Newswire - Mon Jul 11, 2022

BOSTON, July 11, 2022 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to defeating cancer using RNA...

RNAZ : 0.8681 (-7.65%)
TransCode Therapeutics To Participate at H.C. Wainwright Global Investment Conference Globe Newswire - Fri May 20, 2022

BOSTON, May 20, 2022 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) today announced that it will be presenting at the H.C. Wainwright...

RNAZ : 0.8681 (-7.65%)

Barchart Exclusives

3 Mid-Cap Energy Dividend Stocks to Scoop Up Now Barchart - Wed Jul 3, 6:30PM CDT
Amid predictions of higher oil prices, here are three dividend-paying energy stocks that are worth adding to your portfolio. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot